Aesthetic Sciences, a Palo Alto company with no Web site, has raised $6 million in a first round of venture capital to develop aesthetic medicine and incontinence products.

Investors are Domain Associates and New Leaf Venture Partners. Aesthetic Sciences is secretive, and was founded in 2004.

Aesthetic Sciences Chairman and CEO Gary S. Petersmeyer, in a statement, said aging baby boomers are driving demand for facial aesthetic procedures, and that growth in this area will see a double digit annual rate for a number of years.

The company said it is “developing polymers designed to solve the long-standing issue of short persistence of many of the current products in the fields of aesthetic medicine and incontinence. This technology gives Aesthetic Sciences the potential to provide physicians and patients with a choice of products which will offer a range of persistence from over one year to more than five years.”

“These extraordinary new materials have the potential to become the #1 choice in the dermal filler category. We believe Aesthetic Sciences can become a leader in this segment.”

It has licensed Landec’s polymer technology.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.